APO Research
Talk to an analyst

APO RESEARCH · REPORT

Short-Acting Anesthetic

Compare research editions
View pricing & licenses

Selected research

Industry Research

Short-Acting Anesthetic Industry Research Report 2026

29 December 2025134 pages

Choose your research edition.

Industry ResearchShort-Acting Anesthetic Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Short-Acting Anesthetic Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Short-Acting Anesthetic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short-Acting Anesthetic Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Short-Acting Anesthetic Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Short-Acting Anesthetic market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Short-Acting Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Short-Acting Anesthetic is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Short-Acting Anesthetic is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Short-Acting Anesthetic include Aspen Pharmacare, Baxter Healthcare, Dr. Reddy's Laboratories, Fresenius-Kabi, Hikma Pharmaceuticals, Hospira, Paion, Piramal Critical Care and Septodont, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Short-Acting Anesthetic market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Short-Acting Anesthetic Market by Company

Aspen Pharmacare

Baxter Healthcare

Dr. Reddy's Laboratories

Fresenius-Kabi

Hikma Pharmaceuticals

Hospira

Paion

Piramal Critical Care

Septodont

AstraZeneca

AbbVie

B. Braun

Cisen Pharmaceutical

Pfizer

Yingke Biopharmaceutical

SSY Group

Baili-Pharm

Eisai

Short-Acting Anesthetic Segment by Type

Local

General

Short-Acting Anesthetic Segment by Application

Hospital

Clinic

Short-Acting Anesthetic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-Acting Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short-Acting Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-Acting Anesthetic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Short-Acting Anesthetic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Short-Acting Anesthetic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Short-Acting Anesthetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Short-Acting Anesthetic Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Short-Acting Anesthetic Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Short-Acting Anesthetic Sales Market Share by Manufacturers (2021-2026) Table 8. Global Short-Acting Anesthetic Revenue of Manufacturers (2021-2026) Table 9. Global Short-Acting Anesthetic Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Short-Acting Anesthetic Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Short-Acting Anesthetic Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Short-Acting Anesthetic, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Short-Acting Anesthetic, Product Type & Application Table 14. Global Short-Acting Anesthetic Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Short-Acting Anesthetic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Aspen Pharmacare Company Information Table 19. Aspen Pharmacare Business Overview Table 20. Aspen Pharmacare Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Aspen Pharmacare Short-Acting Anesthetic Product Portfolio Table 22. Aspen Pharmacare Recent Developments Table 23. Baxter Healthcare Company Information Table 24. Baxter Healthcare Business Overview Table 25. Baxter Healthcare Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Baxter Healthcare Short-Acting Anesthetic Product Portfolio Table 27. Baxter Healthcare Recent Developments Table 28. Dr. Reddy's Laboratories Company Information Table 29. Dr. Reddy's Laboratories Business Overview Table 30. Dr. Reddy's Laboratories Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio Table 32. Dr. Reddy's Laboratories Recent Developments Table 33. Fresenius-Kabi Company Information Table 34. Fresenius-Kabi Business Overview Table 35. Fresenius-Kabi Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Fresenius-Kabi Short-Acting Anesthetic Product Portfolio Table 37. Fresenius-Kabi Recent Developments Table 38. Hikma Pharmaceuticals Company Information Table 39. Hikma Pharmaceuticals Business Overview Table 40. Hikma Pharmaceuticals Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio Table 42. Hikma Pharmaceuticals Recent Developments Table 43. Hospira Company Information Table 44. Hospira Business Overview Table 45. Hospira Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Hospira Short-Acting Anesthetic Product Portfolio Table 47. Hospira Recent Developments Table 48. Paion Company Information Table 49. Paion Business Overview Table 50. Paion Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Paion Short-Acting Anesthetic Product Portfolio Table 52. Paion Recent Developments Table 53. Piramal Critical Care Company Information Table 54. Piramal Critical Care Business Overview Table 55. Piramal Critical Care Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Piramal Critical Care Short-Acting Anesthetic Product Portfolio Table 57. Piramal Critical Care Recent Developments Table 58. Septodont Company Information Table 59. Septodont Business Overview Table 60. Septodont Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Septodont Short-Acting Anesthetic Product Portfolio Table 62. Septodont Recent Developments Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. AstraZeneca Short-Acting Anesthetic Product Portfolio Table 67. AstraZeneca Recent Developments Table 68. AbbVie Company Information Table 69. AbbVie Business Overview Table 70. AbbVie Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. AbbVie Short-Acting Anesthetic Product Portfolio Table 72. AbbVie Recent Developments Table 73. B. Braun Company Information Table 74. B. Braun Business Overview Table 75. B. Braun Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. B. Braun Short-Acting Anesthetic Product Portfolio Table 77. B. Braun Recent Developments Table 78. Cisen Pharmaceutical Company Information Table 79. Cisen Pharmaceutical Business Overview Table 80. Cisen Pharmaceutical Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio Table 82. Cisen Pharmaceutical Recent Developments Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Short-Acting Anesthetic Product Portfolio Table 87. Pfizer Recent Developments Table 88. Yingke Biopharmaceutical Company Information Table 89. Yingke Biopharmaceutical Business Overview Table 90. Yingke Biopharmaceutical Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio Table 92. Yingke Biopharmaceutical Recent Developments Table 93. SSY Group Company Information Table 94. SSY Group Business Overview Table 95. SSY Group Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. SSY Group Short-Acting Anesthetic Product Portfolio Table 97. SSY Group Recent Developments Table 98. Baili-Pharm Company Information Table 99. Baili-Pharm Business Overview Table 100. Baili-Pharm Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Baili-Pharm Short-Acting Anesthetic Product Portfolio Table 102. Baili-Pharm Recent Developments Table 103. Eisai Company Information Table 104. Eisai Business Overview Table 105. Eisai Short-Acting Anesthetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Eisai Short-Acting Anesthetic Product Portfolio Table 107. Eisai Recent Developments Table 108. Global Short-Acting Anesthetic Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Short-Acting Anesthetic Sales by Region (2021-2026) & (K Units) Table 110. Global Short-Acting Anesthetic Sales Market Share by Region (2021-2026) Table 111. Global Short-Acting Anesthetic Sales by Region (2027-2032) & (K Units) Table 112. Global Short-Acting Anesthetic Sales Market Share by Region (2027-2032) Table 113. Global Short-Acting Anesthetic Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Short-Acting Anesthetic Revenue Market Share by Region (2021-2026) Table 115. Global Short-Acting Anesthetic Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Short-Acting Anesthetic Revenue Market Share by Region (2027-2032) Table 117. North America Short-Acting Anesthetic Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 119. North America Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 120. North America Short-Acting Anesthetic Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Short-Acting Anesthetic Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Short-Acting Anesthetic Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 124. Europe Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 125. Europe Short-Acting Anesthetic Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Short-Acting Anesthetic Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Short-Acting Anesthetic Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Short-Acting Anesthetic Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Short-Acting Anesthetic Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Short-Acting Anesthetic Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 134. South America Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 135. South America Short-Acting Anesthetic Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Short-Acting Anesthetic Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Short-Acting Anesthetic Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Short-Acting Anesthetic Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Short-Acting Anesthetic Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Short-Acting Anesthetic Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Short-Acting Anesthetic Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Short-Acting Anesthetic Sales by Type (2021-2026) & (K Units) Table 143. Global Short-Acting Anesthetic Sales by Type (2027-2032) & (K Units) Table 144. Global Short-Acting Anesthetic Sales Market Share by Type (2021-2026) Table 145. Global Short-Acting Anesthetic Sales Market Share by Type (2027-2032) Table 146. Global Short-Acting Anesthetic Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Short-Acting Anesthetic Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2026) Table 149. Global Short-Acting Anesthetic Revenue Market Share by Type (2027-2032) Table 150. Global Short-Acting Anesthetic Price by Type (2021-2026) & (US$/Unit) Table 151. Global Short-Acting Anesthetic Price by Type (2027-2032) & (US$/Unit) Table 152. Global Short-Acting Anesthetic Sales by Application (2021-2026) & (K Units) Table 153. Global Short-Acting Anesthetic Sales by Application (2027-2032) & (K Units) Table 154. Global Short-Acting Anesthetic Sales Market Share by Application (2021-2026) Table 155. Global Short-Acting Anesthetic Sales Market Share by Application (2027-2032) Table 156. Global Short-Acting Anesthetic Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Short-Acting Anesthetic Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2026) Table 159. Global Short-Acting Anesthetic Revenue Market Share by Application (2027-2032) Table 160. Global Short-Acting Anesthetic Price by Application (2021-2026) & (US$/Unit) Table 161. Global Short-Acting Anesthetic Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Short-Acting Anesthetic Distributors List Table 165. Short-Acting Anesthetic Customers List Table 166. Short-Acting Anesthetic Industry Trends Table 167. Short-Acting Anesthetic Industry Drivers Table 168. Short-Acting Anesthetic Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Short-Acting Anesthetic Product Image Figure 5. Global Short-Acting Anesthetic Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Short-Acting Anesthetic Market Size (2021-2032) & (US$ Million) Figure 7. Global Short-Acting Anesthetic Sales (2021-2032) & (K Units) Figure 8. Global Short-Acting Anesthetic Average Price (US$/Unit) & (2021-2032) Figure 9. Local Product Image Figure 10. General Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Global Short-Acting Anesthetic Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Short-Acting Anesthetic, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Short-Acting Anesthetic Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Short-Acting Anesthetic Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Short-Acting Anesthetic Sales by Region in 2025 Figure 19. Global Short-Acting Anesthetic Revenue by Region in 2025 Figure 20. North America Short-Acting Anesthetic Market Size by Country in 2025 Figure 21. North America Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 22. North America Short-Acting Anesthetic Revenue Market Share by Country (2021-2032) Figure 23. United States Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Short-Acting Anesthetic Market Size by Country in 2025 Figure 26. Europe Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 27. Europe Short-Acting Anesthetic Revenue Market Share by Country (2021-2032) Figure 28. Germany Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Short-Acting Anesthetic Market Size by Country in 2025 Figure 34. Asia Pacific Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Short-Acting Anesthetic Revenue Market Share by Country (2021-2032) Figure 36. China Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Short-Acting Anesthetic Market Size by Country in 2025 Figure 45. South America Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 46. South America Short-Acting Anesthetic Revenue Market Share by Country (2021-2032) Figure 47. Mexico Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Middle East and Africa Short-Acting Anesthetic Market Size by Country in 2025 Figure 51. Middle East and Africa Short-Acting Anesthetic Sales Market Share by Country (2021-2032) Figure 52. Middle East and Africa Short-Acting Anesthetic Revenue Market Share by Country (2021-2032) Figure 53. Turkey Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Saudi Arabia Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. UAE Short-Acting Anesthetic Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Global Short-Acting Anesthetic Sales Market Share by Type (2021-2032) Figure 57. Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2032) Figure 58. Global Short-Acting Anesthetic Price (US$/Unit) by Type (2021-2032) Figure 59. Global Short-Acting Anesthetic Sales Market Share by Application (2021-2032) Figure 60. Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2032) Figure 61. Global Short-Acting Anesthetic Price (US$/Unit) by Application (2021-2032) Figure 62. Short-Acting Anesthetic Value Chain Figure 63. Short-Acting Anesthetic Production Mode & Process Figure 64. Direct Comparison with Distribution Share Figure 65. Distributors Profiles Figure 66. Short-Acting Anesthetic Industry Opportunities and Challenges

Scope & coverage.

Types
  • Local
  • General
Applications
  • Hospital
  • Clinic
Companies covered
  • Aspen Pharmacare
  • Baxter Healthcare
  • Dr. Reddy's Laboratories
  • Fresenius-Kabi
  • Hikma Pharmaceuticals
  • Hospira
  • Paion
  • Piramal Critical Care
  • Septodont
  • AstraZeneca
  • AbbVie
  • B. Braun
  • Cisen Pharmaceutical
  • Pfizer
  • Yingke Biopharmaceutical
  • SSY Group
  • Baili-Pharm
  • Eisai

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Short-Acting Anesthetic Market Size (2021-2032)
  4. 2.2.2 Global Short-Acting Anesthetic Sales (2021-2032)
  5. 2.2.3 Global Short-Acting Anesthetic Market Average Price (2021-2032)
  6. 2.3 Short-Acting Anesthetic by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Local
  9. 2.3.3 General
  10. 2.4 Short-Acting Anesthetic by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Short-Acting Anesthetic Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Short-Acting Anesthetic Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Short-Acting Anesthetic Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Short-Acting Anesthetic Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Short-Acting Anesthetic Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Short-Acting Anesthetic, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Short-Acting Anesthetic, Product Type & Application
  8. 3.8 Global Manufacturers of Short-Acting Anesthetic, Established Date
  9. 3.9 Global Short-Acting Anesthetic Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Aspen Pharmacare
  2. 4.1.1 Aspen Pharmacare Company Information
  3. 4.1.2 Aspen Pharmacare Business Overview
  4. 4.1.3 Aspen Pharmacare Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Aspen Pharmacare Short-Acting Anesthetic Product Portfolio
  6. 4.1.5 Aspen Pharmacare Recent Developments
  7. 4.2 Baxter Healthcare
  8. 4.2.1 Baxter Healthcare Company Information
  9. 4.2.2 Baxter Healthcare Business Overview
  10. 4.2.3 Baxter Healthcare Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Baxter Healthcare Short-Acting Anesthetic Product Portfolio
  12. 4.2.5 Baxter Healthcare Recent Developments
  13. 4.3 Dr. Reddy's Laboratories
  14. 4.3.1 Dr. Reddy's Laboratories Company Information
  15. 4.3.2 Dr. Reddy's Laboratories Business Overview
  16. 4.3.3 Dr. Reddy's Laboratories Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Dr. Reddy's Laboratories Short-Acting Anesthetic Product Portfolio
  18. 4.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 4.4 Fresenius-Kabi
  20. 4.4.1 Fresenius-Kabi Company Information
  21. 4.4.2 Fresenius-Kabi Business Overview
  22. 4.4.3 Fresenius-Kabi Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Fresenius-Kabi Short-Acting Anesthetic Product Portfolio
  24. 4.4.5 Fresenius-Kabi Recent Developments
  25. 4.5 Hikma Pharmaceuticals
  26. 4.5.1 Hikma Pharmaceuticals Company Information
  27. 4.5.2 Hikma Pharmaceuticals Business Overview
  28. 4.5.3 Hikma Pharmaceuticals Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hikma Pharmaceuticals Short-Acting Anesthetic Product Portfolio
  30. 4.5.5 Hikma Pharmaceuticals Recent Developments
  31. 4.6 Hospira
  32. 4.6.1 Hospira Company Information
  33. 4.6.2 Hospira Business Overview
  34. 4.6.3 Hospira Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hospira Short-Acting Anesthetic Product Portfolio
  36. 4.6.5 Hospira Recent Developments
  37. 4.7 Paion
  38. 4.7.1 Paion Company Information
  39. 4.7.2 Paion Business Overview
  40. 4.7.3 Paion Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Paion Short-Acting Anesthetic Product Portfolio
  42. 4.7.5 Paion Recent Developments
  43. 4.8 Piramal Critical Care
  44. 4.8.1 Piramal Critical Care Company Information
  45. 4.8.2 Piramal Critical Care Business Overview
  46. 4.8.3 Piramal Critical Care Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Piramal Critical Care Short-Acting Anesthetic Product Portfolio
  48. 4.8.5 Piramal Critical Care Recent Developments
  49. 4.9 Septodont
  50. 4.9.1 Septodont Company Information
  51. 4.9.2 Septodont Business Overview
  52. 4.9.3 Septodont Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Septodont Short-Acting Anesthetic Product Portfolio
  54. 4.9.5 Septodont Recent Developments
  55. 4.10 AstraZeneca
  56. 4.10.1 AstraZeneca Company Information
  57. 4.10.2 AstraZeneca Business Overview
  58. 4.10.3 AstraZeneca Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 AstraZeneca Short-Acting Anesthetic Product Portfolio
  60. 4.10.5 AstraZeneca Recent Developments
  61. 4.11 AbbVie
  62. 4.11.1 AbbVie Company Information
  63. 4.11.2 AbbVie Business Overview
  64. 4.11.3 AbbVie Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 AbbVie Short-Acting Anesthetic Product Portfolio
  66. 4.11.5 AbbVie Recent Developments
  67. 4.12 B. Braun
  68. 4.12.1 B. Braun Company Information
  69. 4.12.2 B. Braun Business Overview
  70. 4.12.3 B. Braun Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 B. Braun Short-Acting Anesthetic Product Portfolio
  72. 4.12.5 B. Braun Recent Developments
  73. 4.13 Cisen Pharmaceutical
  74. 4.13.1 Cisen Pharmaceutical Company Information
  75. 4.13.2 Cisen Pharmaceutical Business Overview
  76. 4.13.3 Cisen Pharmaceutical Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Cisen Pharmaceutical Short-Acting Anesthetic Product Portfolio
  78. 4.13.5 Cisen Pharmaceutical Recent Developments
  79. 4.14 Pfizer
  80. 4.14.1 Pfizer Company Information
  81. 4.14.2 Pfizer Business Overview
  82. 4.14.3 Pfizer Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Pfizer Short-Acting Anesthetic Product Portfolio
  84. 4.14.5 Pfizer Recent Developments
  85. 4.15 Yingke Biopharmaceutical
  86. 4.15.1 Yingke Biopharmaceutical Company Information
  87. 4.15.2 Yingke Biopharmaceutical Business Overview
  88. 4.15.3 Yingke Biopharmaceutical Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Yingke Biopharmaceutical Short-Acting Anesthetic Product Portfolio
  90. 4.15.5 Yingke Biopharmaceutical Recent Developments
  91. 4.16 SSY Group
  92. 4.16.1 SSY Group Company Information
  93. 4.16.2 SSY Group Business Overview
  94. 4.16.3 SSY Group Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 SSY Group Short-Acting Anesthetic Product Portfolio
  96. 4.16.5 SSY Group Recent Developments
  97. 4.17 Baili-Pharm
  98. 4.17.1 Baili-Pharm Company Information
  99. 4.17.2 Baili-Pharm Business Overview
  100. 4.17.3 Baili-Pharm Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Baili-Pharm Short-Acting Anesthetic Product Portfolio
  102. 4.17.5 Baili-Pharm Recent Developments
  103. 4.18 Eisai
  104. 4.18.1 Eisai Company Information
  105. 4.18.2 Eisai Business Overview
  106. 4.18.3 Eisai Short-Acting Anesthetic Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Eisai Short-Acting Anesthetic Product Portfolio
  108. 4.18.5 Eisai Recent Developments
5 Global Short-Acting Anesthetic Market Scenario by Region
  1. 5.1 Global Short-Acting Anesthetic Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Short-Acting Anesthetic Sales by Region: 2021-2032
  3. 5.2.1 Global Short-Acting Anesthetic Sales by Region: 2021-2026
  4. 5.2.2 Global Short-Acting Anesthetic Sales by Region: 2027-2032
  5. 5.3 Global Short-Acting Anesthetic Revenue by Region: 2021-2032
  6. 5.3.1 Global Short-Acting Anesthetic Revenue by Region: 2021-2026
  7. 5.3.2 Global Short-Acting Anesthetic Revenue by Region: 2027-2032
  8. 5.4 North America Short-Acting Anesthetic Market Facts & Figures by Country
  9. 5.4.1 North America Short-Acting Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Short-Acting Anesthetic Sales by Country (2021-2032)
  11. 5.4.3 North America Short-Acting Anesthetic Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Short-Acting Anesthetic Market Facts & Figures by Country
  15. 5.5.1 Europe Short-Acting Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Short-Acting Anesthetic Sales by Country (2021-2032)
  17. 5.5.3 Europe Short-Acting Anesthetic Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Short-Acting Anesthetic Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Short-Acting Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Short-Acting Anesthetic Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Short-Acting Anesthetic Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Short-Acting Anesthetic Market Facts & Figures by Country
  35. 5.7.1 South America Short-Acting Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Short-Acting Anesthetic Sales by Country (2021-2032)
  37. 5.7.3 South America Short-Acting Anesthetic Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Short-Acting Anesthetic Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Short-Acting Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Short-Acting Anesthetic Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Short-Acting Anesthetic Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Short-Acting Anesthetic Sales by Type (2021-2032)
  2. 6.1.1 Global Short-Acting Anesthetic Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Short-Acting Anesthetic Sales Market Share by Type (2021-2032)
  4. 6.2 Global Short-Acting Anesthetic Revenue by Type (2021-2032)
  5. 6.2.1 Global Short-Acting Anesthetic Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Short-Acting Anesthetic Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Short-Acting Anesthetic Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Short-Acting Anesthetic Sales by Application (2021-2032)
  2. 7.1.1 Global Short-Acting Anesthetic Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Short-Acting Anesthetic Sales Market Share by Application (2021-2032)
  4. 7.2 Global Short-Acting Anesthetic Revenue by Application (2021-2032)
  5. 7.2.1 Global Short-Acting Anesthetic Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Short-Acting Anesthetic Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Short-Acting Anesthetic Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Short-Acting Anesthetic Value Chain Analysis
  2. 8.1.1 Short-Acting Anesthetic Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Short-Acting Anesthetic Production Mode & Process
  5. 8.2 Short-Acting Anesthetic Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Short-Acting Anesthetic Distributors
  8. 8.2.3 Short-Acting Anesthetic Customers
9 Global Short-Acting Anesthetic Analyzing Market Dynamics
  1. 9.1 Short-Acting Anesthetic Industry Trends
  2. 9.2 Short-Acting Anesthetic Industry Drivers
  3. 9.3 Short-Acting Anesthetic Industry Opportunities and Challenges
  4. 9.4 Short-Acting Anesthetic Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst